Macrophages within tumors can be activated by tumor-associated antigens that they can further process and present via their MHC-II to CD4+ helper T cells and CD8+ cytotoxic T cells (132), to promote effective antitumor adaptive immune responses. The gene discussed is CD8A; the disease is neoplasm.